Counterfeit Ozempic-labelled pens are being bought in Australia.
The Therapeutic Items Administration (TGA) and the Australian Border Pressure (ABF) have detected the pretend Ozempic-labelled pens.
The TGA is warning individuals to search for spelling errors, instruction leaflets not in English, unsealed packaging, or modifications in medication measurement, form, or look. These are indicators that the medication has not been produced by the unique producer or is being illegally bought within the fallacious market.
The 2 merchandise which have prompted the alert each look like relabelled insulin pens. The top ap is blue (not gray), the dosage barrel is in a unique place, the sticker isn’t adhering correctly to the pen, and the packaging is poor high quality.
There has already been a life-threatening incident in Australia with an individual utilizing a pretend pen labelled as Ozempic which contained insulin. This pen was purchased abroad. Unintended use of insulin could cause dangerously low life-threatening blood glucose ranges.
The batch numbers labelled on the pens - NPSG234 detected by ABF and JS7A925 from the hostile occasion – have been confirmed as not real batch numbers by Novo Nordisk, the producer of Ozempic.
The ABF stated the merchandise have been bought on-line from an abroad web site and imported below the non-public importation scheme.
